Send us Feedback

Inspire Pharmaceuticals (ISPH)
Analysis
SUMMARY
BULLS
BEARS
TOPICS
Data
DATA CENTRAL
STOCK CHART
Financials
SEC FILINGS
BALANCE
INCOME
CASH FLOW

ISPH » Topics » Item 13. Certain Relationships and Related Transactions, and Director Independence.

These excerpts taken from the ISPH 10-K filed Mar 13, 2009.

Item 13. Certain Relationships and Related Transactions, and Director Independence.

 

The information required by this item is incorporated by reference to the material responsive to this item contained in our Proxy Statement to be filed in connection with our 2009 Annual Meeting of Stockholders.

 

Item 13. Certain Relationships and Related Transactions, and
Director Independence.

 

The information required by this
item is incorporated by reference to the material responsive to this item contained in our Proxy Statement to be filed in connection with our 2009 Annual Meeting of Stockholders.

SIZE="1"> 

These excerpts taken from the ISPH 10-K filed Mar 14, 2008.

Item 13. Certain Relationships and Related Transactions, and Director Independence.

 

The information required by this item is incorporated by reference to the material responsive to this item contained in our Proxy Statement to be filed in connection with our 2008 Annual Meeting of Stockholders.

 


Item 13. Certain Relationships and Related Transactions, and Director Independence.

 

STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%">The information required by this item is incorporated by reference to the material responsive to this item contained in our Proxy Statement to be filed in
connection with our 2008 Annual Meeting of Stockholders.

 

This excerpt taken from the ISPH 10-K filed Mar 16, 2007.

ITEM 13. CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS, AND DIRECTOR INDEPENDENCE

 

The information required by this item is incorporated by reference to the material responsive to this item contained in our Proxy Statement to be filed in connection with our 2007 Annual Meeting of Stockholders.

 

71

Table of Contents

EXCERPTS ON THIS PAGE:

10-K (2 sections)
Mar 13, 2009
10-K (2 sections)
Mar 14, 2008
10-K
Mar 16, 2007

RELATED TOPICS for ISPH:

"Item 13. Certain Relationships and Related Transactions, and Director Independence." elsewhere:

Allos Therapeutics (ALTH)
Arena Pharmaceuticals (ARNA)
Cubist Pharmaceuticals (CBST)
Cephalon (CEPH)
CoreSite Realty Corp (COR)
DepoMed (DEPO)
Isis Pharmaceuticals (ISIS)
Lannett Co (LCI)
Medicines Company (MDCO)
NitroMed (NTMD)
Orexigen Therapeutics (OREX)
PDL BioPharma (PDLI)
Astex Pharmaceuticals, Inc (SUPG)
United Therapeutics (UTHR)
Warner Chilcott (WCRX)
Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki